Evaluation of urinary excretion of dolutegravir or emtricitabine/tenofovir/elvitegravir/cobicistat antiretroviral-based regimens using plasma and urine trough concentration

by Jérémy Lourenco, Gilles Peytavin, Véronique Avetttand-Fenoel, Minh-Patrick Le, Claire Rouzaud, Fanny Lanternier, Caroline Charlier-Woerther, Fatima Touam, Carole Louisin, Olivier Lortholary, Claudine Duvivier
Published 2018-05-01